Teja M. Kapoor MD
Director, Columbia Sjogrens Center Program Director, Rheumatology Fellowship Director of Education for Division of Rheumatology Co-Director, Columbia Medicine Grand Rounds Committee
161 Fort Washington AvenueNew York, NY 10032
Overview of Dr. Kapoor
Dr. Teja Kapoor is an academic rheumatologist at Columbia University Irving Medical Center-NY Presbyterian. She is the Director of the interdisciplinary Columbia Sjogren's Center and Fellowship Director for the Columbia Rheumatology Training Program. She completed her medical education at New York Medical College in 2006, followed by an internal medicine residency at Rutgers Health/Robert Wood Johnson Medical School from 2010 to 2013, and a rheumatology fellowship at New York Presbyterian Hospital (Columbia Campus) from 2013 to 2015. Dr. Kapoor has published several notable papers, including works on hydroxychloroquine's role during the COVID-19 pandemic and its impact on systemic lupus erythematosus, platelet activation markers, the prevalence of PML in lupus, and cardiac diagnostics in lupus. Her research has been recognized and cited by peers, contributing valuable insights into her field.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Rheumatology, 2013 - 2015
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 2010 - 2013
New York Medical CollegeClass of 2006
Certifications & Licensure
NJ State Medical License 2014 - 2027
NY State Medical License 2015 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2017
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2017
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2017
Publications & Presentations
PubMed
- 3 citationsThe Rise and Fall of Hydroxychloroquine with the COVID-19 Pandemic: Narrative Review of Selected Data.Wei Tang, Wei Tang, Leila Khalili, Jon T. Giles, Yevgeniya Gartshteyn
Rheumatology and Therapy. 2021-05-24 - 10 citationsPlatelet bound complement split product (PC4d) is a marker of platelet activation and arterial vascular events in systemic lupus erythematosusYevgeniya Gartshteyn, Adam Mor, Daichi Shimbo, Leila Khalili, Teja Kapoor
Clinical Immunology. 2021-05-11 - 8 citationsPrevalence of progressive multifocal leukoencephalopathy (PML) in adults and children with systemic lupus erythematosusTeja Kapoor, Pooja Mahadeshwar, Joyce Hui-Yuen, Kayla M. Quinnies, Nicholas P. Tatonetti
Lupus Science & Medicine. 2020-06-01
Press Mentions
Upcoming US Clinical Trial Will Test CLN-978 as Sjögren’s TreatmentMay 5th, 2025- Overcoming Barriers in Sjögren Disease CareJanuary 9th, 2026
- Advice on the Challenges in Detecting and Managing Sjögren DiseaseJanuary 9th, 2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
